cannabidiol

FDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products

April 4, 2019

In recent years, we’ve seen a growing interest in the development of therapies and other FDA-regulated consumer products derived from cannabis (Cannabis sativa L.) and its components, including cannabidiol (CBD). This interest spans the range of product categories that the agency regulates. For example, we’ve seen, or heard of interest in, products containing cannabis or […]

Read More

Cannabidiol shows sustained effects against depression for seven days

September 13, 2018

A recent study found that a single dose of cannabidiol in rats with symptoms of depression was highly effective, eliminating the symptoms on the same day and maintaining the beneficial effects for a week. The findings reinforce those of prior research showing that cannabidiol, a component of Cannabis sativa, the plant most commonly used to […]

Read More

Cannabis extract helps reset brain function in psychosis

September 6, 2018

Research from King’s College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psychosis. Results from a new MRC-funded trial, published in?JAMA Psychiatry, provide the first evidence of how cannabidiol acts in the brain to reduce psychotic symptoms. Cannabidiol, also referred to […]

Read More

World-Renowned Neurosurgeon, Health and Nutrition Expert, Dr. Joseph Maroon, Joins CV Sciences, Inc. Board of Directors

August 9, 2018

CV Sciences, Inc.?(OTCQB:CVSI) (the “Company,” “CV Sciences,” “our” or “we”) is pleased to announce the appointment of Joseph Maroon, MD, FACS (“Dr. Maroon”), to its Board of Directors. Dr. Maroon is a clinical professor and vice chairman of the Department of Neurological Surgery and the Heindl Scholar in Neuroscience at the University of Pittsburgh Medical […]

Read More